Highlights from

WCD 2019

World Congress of Dermatology

Milan 10-15 June 2019

Various guidelines with much overlap

Different guidelines for the management of hidradenitis suppurativa have emerged in the recent years. As they are all based on the same data of evidence, a joint venture for consolidation would be desirable, argued Prof. Gregor Jemec (Zealand University Hospital, Denmark).

Hidradenitis suppurativa (HS) is a chronic, systemic condition with recurrent painful deep-seated nodules, sinus tracts, and abscesses that gravely impacts quality of life [1]. Appropriate treatment is often delayed due to under-recognition. “Many different organisations have created guidelines for the treatment of hidradenitis suppurativa independently of each other, and my conclusion is that we should really work together on these guidelines,” said Prof. Jemec [2]. The European guidelines were published in 2015. They were followed by the British guidelines in 2018 and North American in 2019 [3,4,5]. These guidelines are based on the same body of evidence that lead them to similar recommendations, including: 1) acknowledgement of patient’s morbidity; 2) medical treatment with tetracyclines, in combination with clindamycin and rifampicin, or adalimumab; 3) surgery and supportive care [2]. “So, we are all harvesting the same fruits over and over again and we are wasting immense amounts of work in doing this from scratch,” explained Prof. Jemec, and he was happy to announce that during the WCD, the leadership of the various involved organisations have discussed the possibilities of future collaboration on this matter.

  1. Vekic DA. 24th World Congress of Dermatology, 10-15 June 2019, Milan, Italy.
  2. Jemec G. 24th World Congress of Dermatology, 10-15 June 2019, Milan, Italy.
  3. Zouboulis CC, et al. J Eur Acad Dermatol Venereol. 2015;29: 619-44.
  4. Ingram JR, et al. Br J Dermatol. 2019;180:1009-1017.
  5. Alikhan A, et al. J Am Acad Dermatol. 2019;81:91-101.

The content and interpretation of these conference highlights are the views and comments of the speakers/authors.